Howard Martin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Howard Martin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Agnieszka Bierzynska
Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
1 shared publication - Allan J. Richards
Vitreoretinal Research Group, John van Geest Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0PY, UK
1 shared publication - Kim Brugger
Department of Clinical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
1 shared publication - Lucy Plumb
Population Health Sciences, University of Bristol Medical School, Bristol, UK
1 shared publication - Martin P. Snead
Stickler’s Higher Specialist Service, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 0PY, UK
1 shared publication - Matko Marlais
Department of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
1 shared publication
Latest Publications
- Open Access
From First to Second: How Stickler’s Diagnostic Genetics Has Evolved to Match Sequencing Technologies
Diagnostic genetics within the United Kingdom National Health Service (NHS) has undergone many stepwise improvements in technology since the completion of the human genome project in 2003. Although Sanger sequencing has remained a cornerstone of the diagnostic sequencing arena, the human genome reference sequence has enabled next-generation sequencing (more accurately named ‘second-generation sequencing’), to rapidly surpass it in scale and potential. This mini review discusses such developments from the viewpoint of the Stickler’s higher specialist service, detailing the considerations and improvements to diagnostic sequencing implemented since 2003.
Open AccessFrom First to Second: How Stickler’s Diagnostic Genetics Has Evolved to Match Sequencing Technologies
Diagnostic genetics within the United Kingdom National Health Service (NHS) has undergone many stepwise improvements in technology since the completion of the human genome project in 2003. Although Sanger sequencing has remained a cornerstone of the diagnostic sequencing arena, the human genome reference sequence has enabled next-generation sequencing (more accurately named ‘second-generation sequencing’), to rapidly surpass it in scale and potential. This mini review discusses such developments from the viewpoint of the Stickler’s higher specialist service, detailing the considerations and improvements to diagnostic sequencing implemented since 2003.
- Open Access
- 9 May 2014
- Published by Springer Nature in BMC Nephrology
- Vol. 15 (1) , 76
Unilateral hypoplastic kidney - a novel highly penetrant feature of familial juvenile hyperuricaemic nephropathy
Familial juvenile hyperuricaemic nephropathy is a rare inherited nephropathy with genetic heterogeneity. Categorised by genetic defect, mutations in uromodulin (UMOD), renin (REN) and hepatocyte nuclear factor-1β (HNF-1β) genes as well as linkage to chromosome 2p22.1-21 have previously been identified. Knowledge of the genetics of this phenotype has provided important clues to developmental pathways in the kidney.
- 9 May 2014
- Published by Springer Nature in BMC Nephrology
- Vol. 15 (1) , 76
Open AccessUnilateral hypoplastic kidney - a novel highly penetrant feature of familial juvenile hyperuricaemic nephropathy
Familial juvenile hyperuricaemic nephropathy is a rare inherited nephropathy with genetic heterogeneity. Categorised by genetic defect, mutations in uromodulin (UMOD), renin (REN) and hepatocyte nuclear factor-1β (HNF-1β) genes as well as linkage to chromosome 2p22.1-21 have previously been identified. Knowledge of the genetics of this phenotype has provided important clues to developmental pathways in the kidney.